Is Realty Income the Best Dividend Stock to Buy Long-Term?
Realty Income (NYSE:O) is a longstanding real estate investment trust…
Sell
17
AGIO Quote, Financials, Valuation and Earnings
Last price:
$25.30
Seasonality move
:
12.3%
Day range:
$24.30 - $25.76
52-week range:
$23.42 - $62.58
Dividend yield:
0%
P/E ratio:
2.32x
P/S ratio:
41.48x
P/B ratio:
0.98x
Volume:
1.2M
Avg. volume:
724.5K
1-year change:
-15.46%
Market cap:
$1.5B
Revenue:
$36.5M
EPS (TTM):
$11.34
Agios Pharmaceuticals SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
AGIO
Agios Pharmaceuticals
|
05/02/2024 | 10-Q | 10-Q filing on 05/02/2024 | View Form |
|
AGIO
Agios Pharmaceuticals
|
11/02/2023 | 10-Q | 10-Q filing on 11/02/2023 | View Form |
|
AGIO
Agios Pharmaceuticals
|
08/03/2023 | 10-Q | 10-Q filing on 08/03/2023 | View Form |
|
AGIO
Agios Pharmaceuticals
|
05/04/2023 | 10-Q | 10-Q filing on 05/04/2023 | View Form |
|
AGIO
Agios Pharmaceuticals
|
11/03/2022 | 10-Q | 10-Q filing on 11/03/2022 | View Form |
|
AGIO
Agios Pharmaceuticals
|
08/04/2022 | 10-Q | 10-Q filing on 08/04/2022 | View Form |
|
AGIO
Agios Pharmaceuticals
|
05/05/2022 | 10-Q | 10-Q filing on 05/05/2022 | View Form |
|
AGIO
Agios Pharmaceuticals
|
11/03/2021 | 10-Q | 10-Q filing on 11/03/2021 | View Form |
|
AGIO
Agios Pharmaceuticals
|
07/29/2021 | 10-Q | 10-Q filing on 07/29/2021 | View Form |
|
AGIO
Agios Pharmaceuticals
|
05/07/2021 | 10-Q | 10-Q filing on 05/07/2021 | View Form |
|
AGIO
Agios Pharmaceuticals
|
04/29/2021 | 10-Q | 10-Q filing on 04/29/2021 | View Form |
|
AGIO
Agios Pharmaceuticals
|
11/05/2020 | 10-Q | 10-Q filing on 11/05/2020 | View Form |
|
AGIO
Agios Pharmaceuticals
|
07/30/2020 | 10-Q | 10-Q filing on 07/30/2020 | View Form |
|
AGIO
Agios Pharmaceuticals
|
04/30/2020 | 10-Q | 10-Q filing on 04/30/2020 | View Form |
|
AGIO
Agios Pharmaceuticals
|
02/19/2020 | 10-K | 10-K filing on 02/19/2020 | View Form |
|
AGIO
Agios Pharmaceuticals
|
10/31/2019 | 10-Q | 10-Q filing on 10/31/2019 | View Form |
|
AGIO
Agios Pharmaceuticals
|
08/01/2019 | 10-Q | 10-Q filing on 08/01/2019 | View Form |
|
AGIO
Agios Pharmaceuticals
|
05/02/2019 | 10-Q | 10-Q filing on 05/02/2019 | View Form |
|
AGIO
Agios Pharmaceuticals
|
02/14/2019 | 10-K | 10-K filing on 02/14/2019 | View Form |
|
AGIO
Agios Pharmaceuticals
|
11/01/2018 | 10-Q | 10-Q filing on 11/01/2018 | View Form |
|
AGIO
Agios Pharmaceuticals
|
08/02/2018 | 10-Q | 10-Q filing on 08/02/2018 | View Form |
|
AGIO
Agios Pharmaceuticals
|
05/04/2018 | 10-Q | 10-Q filing on 05/04/2018 | View Form |
|
AGIO
Agios Pharmaceuticals
|
02/14/2018 | 10-K | 10-K filing on 02/14/2018 | View Form |
|
AGIO
Agios Pharmaceuticals
|
11/01/2017 | 10-Q | 10-Q filing on 11/01/2017 | View Form |
|
AGIO
Agios Pharmaceuticals
|
08/08/2017 | 10-Q | 10-Q filing on 08/08/2017 | View Form |
|
AGIO
Agios Pharmaceuticals
|
05/04/2017 | 10-Q | 10-Q filing on 05/04/2017 | View Form |
|
AGIO
Agios Pharmaceuticals
|
02/16/2017 | 10-K | 10-K filing on 02/16/2017 | View Form |
|
AGIO
Agios Pharmaceuticals
|
11/03/2016 | 10-Q | 10-Q filing on 11/03/2016 | View Form |
|
AGIO
Agios Pharmaceuticals
|
08/08/2016 | 10-Q | 10-Q filing on 08/08/2016 | View Form |
|
AGIO
Agios Pharmaceuticals
|
05/09/2016 | 10-Q | 10-Q filing on 05/09/2016 | View Form |
|
AGIO
Agios Pharmaceuticals
|
02/26/2016 | 10-K | 10-K filing on 02/26/2016 | View Form |
|
AGIO
Agios Pharmaceuticals
|
11/06/2015 | 10-Q | 10-Q filing on 11/06/2015 | View Form |
|
AGIO
Agios Pharmaceuticals
|
08/07/2015 | 10-Q | 10-Q filing on 08/07/2015 | View Form |
|
AGIO
Agios Pharmaceuticals
|
05/11/2015 | 10-Q | 10-Q filing on 05/11/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Archer Aviation a Buy, Sell or Hold?
Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…
Down 50%, Is Dell Technologies a Buy?
Dell (NYSE:DELL)’s share price has been on a roller coaster…
Stock Ideas
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Sell
33
BULZ alert for Apr 10
MicroSectors Solactive FANG & Innov 3X Levd ETN [BULZ] is down 15.35% over the past day.
Sell
31
TECS alert for Apr 10
Direxion Daily Technology Bear 3x Shares [TECS] is up 12.66% over the past day.
Sell
48
FNGA alert for Apr 10
MicroSectors FANG+ Index 3X Leveraged ETN [FNGA] is down 13.3% over the past day.
